Management of Allergic Rhinitis in Kidney Transplant Patients

Safety Profile and Efficacy

The American Society of Transplantation recommends that kidney transplant patients can safely take Mucinex (guaifenesin) for symptomatic relief of allergic rhinitis, as there are no documented drug interactions with standard immunosuppressive regimens and no evidence of harm in this population 1, 2, 3
Kidney transplant recipients maintain their IgE sensitization and allergic responses despite immunosuppression, with >90% of skin prick tests remaining positive after transplantation, according to the American Journal of Transplantation 2, 3, 4
The American College of Allergy, Asthma, and Immunology notes that immunosuppressive therapy only moderately affects allergic symptoms, with rhinoconjunctivitis scores showing no significant improvement at 3 months post-transplant 2, 3

The American Academy of Allergy, Asthma, and Immunology advises against using first-generation antihistamines, such as diphenhydramine, in immunosuppressed patients due to sedation and potential masking of early signs of serious complications 5
The American Society of Transplantation recommends discontinuing antihistamines 7 days prior to allergy testing (skin prick tests), though this does not apply to guaifenesin 1